CLINICAL_TRIALS
trial_result
· 2009-05-19
Clinical Trial Update: PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia [Phase 4]
Summary
The Phase 4 PETHEMA LAL-RI/96 trial in standard-risk acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: COMPLETED